“breast-cancer” Archives

Entry Author Date Location
Sanitas Gets FDA Clearance to Market ‘Wellaho’ for Chronically Ill 02/20/13 San Diego
NanoString Starts Selling First Breast Cancer Test in EU 02/19/13 Seattle
Poll: Which of These 10 New Drugs Is Priced Too High? 02/11/13 National
NanoString Gets EU Clearance To Sell Breast Cancer Diagnostic Test 09/27/12 Seattle
Genentech, ImmunoGen Breast Cancer Drug Extends Lives 08/27/12 San Francisco
Three Good Things About BIO 2012, and Four Not-so-Good 06/18/12 National
Will 3-D Thermal Imaging Revolutionize Breast Cancer Detection? 05/18/12 Detroit Ann Arbor
Genentech, ImmunoGen ‘Smart Bomb’ for Breast Cancer Clears Big Hurdle 03/30/12 San Francisco
Genoa Pharma Aims To Satisfy Big Pharma’s Hunger for IPF Drugs 03/30/12 San Diego
AIDS Drugs Were the Start. Let’s See More FDA Accelerated Approvals 03/12/12 National
San Diego’s Aragon Raises $42 Million, Targets Hormone-Driven Cancers 03/06/12 San Diego
NanoString Nails Breast Cancer Study, Challenging Genomic Health 12/08/11 Seattle
Genentech’s Two-Drug Strategy Raises the Bar in Breast Cancer 12/07/11 San Francisco
Genomic Health Wins Medicare Coverage for High-Priced Colon Cancer Test 09/30/11 San Francisco
Genentech, ImmunoGen’s Souped-Up Antibody for Breast Cancer Passes Key Test 09/24/11 San Francisco
Former Genzyme Boss Henri Termeer Gives $10M to MGH for Personalized Medicine 09/13/11 Boston
Lead Syndax Drug Shows Survival Benefits in Breast Cancer Trial 09/06/11 Boston
Video: Seattle Genetics CEO Makes the Case for a $100K Cancer Drug 08/22/11 Seattle
Syndax Moves Closer to Pivotal Trials of Selective Lung Cancer Treatment 07/05/11 Boston
This Drug Didn’t Work for Me. May I Have My $88,000 Back, Please? 06/30/11 Seattle
Genentech Shot Down at FDA Hearing on Avastin for Breast Cancer 06/29/11 San Francisco
Atossa Nabs $6.6M 06/27/11 Seattle
Hale, Royston Join Biocept Board 05/02/11 San Diego
KEW, Led by Millennium Co-Founder, Seeks to Bring Big-Time Cancer Care to Community Clinics 04/27/11 Boston
Think Obamacare Will Suffocate New Drug Development With Price Controls? Think Again 03/21/11 National
ImmunoGen CEO Highlights Two New Souped-Up Antibodies Against Cancer 02/25/11 Boston
Gilead Bets $600M on Cancer, Genentech Gets a Hearing, Jennerex Shows Early Survival Edge, & More Bay Area Life Sciences News 02/25/11 San Francisco
Genentech Gets FDA Hearing 02/24/11 San Francisco
Sanofi Buys Genzyme for $20B, Aveo Inks Deal with Astellas, Hologix Nabs FDA Approval, & More Boston-Area Life Sciences News 02/18/11 Boston
Aveo Pharma Lands $1.4B Deal with Astellas, A Few Months Ahead of Cancer Trial Result 02/16/11 Boston
Page 3 of 5 « previous page · next page »